CLINICAL_TRIALS
trial_result
· 2018-06-01
Clinical Trial Update: Mineralocorticoid Receptor Antagonists in Type 2 Diabetes [Phase 4]
Summary
Phase 4 clinical trial update indicates completion of a study evaluating mineralocorticoid receptor antagonists in Type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Herlev Hospital | Conditions: Diabetes Type 2 | Phase 4 | Status: COMPLETED